Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06218355

IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine

The purpose of this study is to compare two complex, multi-component evidence-based postpartum interventions in underserved populations of lower socioeconomic status in an effort to reduce maternal morbidity and mortality.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Emory University School of Medicine, Atlanta, Georgia, United States

Loading trial locations.

About this study

This large, multi-center randomized controlled trial will compare two multi-component postpartum care models via hybrid type 1 design conducted in two phases. An initial phase (phase 1) will collect baseline data and ensure patient input into final study. In phase 2, women will be randomized. Comparators are evidenced- based approaches: (1) an intensive in-person education with virtual education via push notifications using an electronic health record web portal; (2) a telehealth model using serial encounters. The "push" approach using notifications directly contrasts with the "pull" approach using telehealth visits. Both models include home visit programs. The study population includes patients delivering in two urban, inner-city health systems: Parkland (Dallas, TX) and Grady Memorial (Atlanta, GA). The primary outcome is time from hospital discharge to diagnosis and treatment of a composite of complications in the first 6 weeks. Based upon pilot data, 2349 women will demonstrate a 40% reduction (9 to 5.4 days) with 80% power and two-sided alpha of 0.05. 3500 women will be enrolled (1000 in phase 1; 2500 in phase 2) with anticipated <5% attrition at 6 weeks. Inclusion will be women who deliver liveborn infants. Secondary outcomes include mental health disorders, emergency room visits, hospital admissions, patient knowledge, quality of life and satisfaction, provider satisfaction, and social determinants of health. Women will be followed for one year postpartum.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Postpartum women who deliver a live born infant at Parkland Hospital or Grady Health and receive postpartum care at dedicated community clinics.
  • Due to the nature of the study, all will be women, and all will be postpartum, thus of reproductive age. Postpartum women 18 years of age and older will be considered for inclusion if informed consent can be obtained.

Exclusion criteria

  • Postpartum women who do not deliver at Parkland Hospital or Grady Health will not receive postpartum care in the pre-specified community clinics for Parkland health systems.
  • Patients with a primary language other than English or Spanish.

Treatment and study plan

Intensive Education

Other

Intervention will consist of virtual education and communication through scheduled push notifications

Enhanced Virtual Care

Other

Intervention will utilize a telehealth model consisting of "pull" approach of patient engagement.

Primary outcomes

  1. Composite Healthcare Outcome - time to diagnosis and treatment of postpartum complications after hospital discharge

    Time frame: Up to one year postpartum

    Time to diagnosis and treatment of postpartum complications including hypertension, wound infection, and venous thromboembolism, measured in days. Lower value is considered better, representing timely care.

Secondary outcomes

  1. Edinburgh Postnatal Depression Scale

    Time frame: enrollment, 1 week, 6 weeks, 3 months, 6 months, 1 year postpartum

    screening continuous, numerical; higher value consistent with great risk of postpartum depression

  2. Generalized Anxiety Disorder 7

    Time frame: enrollment, 1 week, 6 weeks, 3 months, 6 months, 1 year postpartum

    screening tool, continuous, numerical, higher value consistent with higher risk of anxiety disorder

  3. Number of patients requiring emergency room visits, % preventable

    Time frame: Up to one year postpartum

    continuous variable, preventability to be determined by preventability panel

  4. Number of patients requiring hospital admissions, % preventable

    Time frame: Up to one year postpartum

    continuous variable, preventability to be determined by preventability panel

  5. Postpartum warning signs knowledge assessment, based on AWOHHN criteria

    Time frame: enrollment, 1 week, 6 weeks, 3 months, 6 months, 1 year postpartum

    Percent scored correct out of 10 total questions

  6. PROMIS-29 questionnaire v 2.1

    Time frame: 6 weeks and 1 year postpartum

    Scales 1-10 for each independent question, with numerical summary score

  7. Healthy People 2030 questionnaire

    Time frame: 6 weeks and 1 year postpartum

    categorical variables selected by the participant

  8. PRAPARE questionnaire

    Time frame: 6 weeks and 1 year postpartum

    categorical and dichotomous variables

  9. Short Assessment of Patient Satisfaction (SAPS)

    Time frame: 6 weeks and 1 year postpartum

    Scale: Extremely dissatisfied to extremely satisfied Score Range is 0-28.

  10. Provider Satisfaction Survey (Quantitative)

    Time frame: Every 6 months throughout the study period

    Scale: Strong agree to strongly disagree; very good to very bad; often to never

  11. Systolic Blood Pressure

    Time frame: enrollment, 1 week, 6 weeks, 3 months, 6 months, 1 year postpartum

    numerical, continuous

  12. Diastolic Blood Pressure

    Time frame: enrollment, 1 week, 6 weeks, 3 months, 6 months, 1 year postpartum

    numerical, continuous

  13. Social Determinants of Health - Healthy People 2030 and PRAPARE questionnaire

    Time frame: enrollment, 6 weeks, 1 year postpartum

    qualitative data, each questions treated as dichotomous or categorical variables

  14. Long-term disease control - diabetes - hemoglobin A1c, LDL, HDL, total cholesterol, triglycerides

    Time frame: enrollment, 6 weeks, 3 months, and 1 year postpartum

    laboratory value - continuous variables

  15. Long-term disease control - hypertension - serum creatinine

    Time frame: enrollment, 6 weeks, 3 months, and 1 year postpartum

    laboratory value - continuous variable

  16. Long-term disease control - liver function test (AST, ALT)

    Time frame: enrollment, 6 weeks, 3 months, and 1 year postpartum

    laboratory value - continuous variables

  17. Long-term disease control - anemia - hemoglobin and hematocrit

    Time frame: enrollment, 6 weeks, 3 months, and 1 year postpartum

    laboratory value - continuous variables

Study contacts

Contact information is provided by the study sponsor or research team.

Jacqueline Catchings, PhD

CONTACT

[email protected]

214-648-7413

Lisa Moseley, RN

CONTACT

[email protected]

214-648-2591

Sponsors and collaborators

Lead sponsor

University of Texas Southwestern Medical Center

Other

Collaborators

  • Patient-Centered Outcomes Research Institute

Registry information

Acronym: IMPACT

Important dates

Study start
2024
Primary completion
2027
Study completion
2028
First posted
Jan 23, 2024
Registry last updated
Mar 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.